GHK-Cu injections are attracting growing interest in aesthetic medicine, regenerative treatments and longevity. But promising biological activity is not the same as established clinical evidence. This article examines what is currently known about injectable GHK-Cu, the difference between topical and injectable copper peptides, and the regulatory and safety considerations South African practitioners should consider when evaluating peptide products.